Global Covid-19 Therapeutic Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Covid-19 Therapeutic Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global Covid-19 Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Immunotherapy
  • 1.4.3 Life Support
  • 1.4.4 Antiviral Medicine
  • 1.4.5 Plasma Therapy
  • 1.4.6 Others
• 1.5 Covid-19 Implications on Market by Application
  • 1.5.1 Global Covid-19 Therapeutic Market Share by Application: 2020 VS 2026
  • 1.5.2 Children
  • 1.5.3 Adult
• 1.6 Coronavirus Disease 2019 (Covid-19): Covid-19 Therapeutic Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Covid-19 Therapeutic Industry
    • 1.6.1.1 Covid-19 Therapeutic Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Covid-19 Therapeutic Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Covid-19 Therapeutic Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Covid-19 Implications on Global Covid-19 Therapeutic Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Covid-19 Therapeutic Growth Trends by Regions
  • 2.2.1 Covid-19 Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Covid-19 Therapeutic Historic Market Share by Regions (2018-2019)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Covid-19 Therapeutic Revenue by Players (2019-2020)
• 3.2 Covid-19 Therapeutic Key Players Head office and Area Served
• 3.3 Key Players Covid-19 Therapeutic Product/Solution/Service
• 3.4 Date of Enter into Covid-19 Therapeutic Market
• 3.5 Key Players Covid-19 Therapeutic Funding/Investment Analysis
• 3.6 Global Key Players Covid-19 Therapeutic Valuation & Market Capitalization
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Global Covid-19 Therapeutic Market Size by Type (2019-2026)

5 Global Covid-19 Therapeutic Market Size by Application (2019-2026)

6 North America

• 6.1 North America Covid-19 Therapeutic Market Forecast (2019-2026)
• 6.2 Covid-19 Therapeutic Key Players in North America (2019-2020)
• 6.3 North America Covid-19 Therapeutic Market Size by Type (2015-2020)
• 6.4 North America Covid-19 Therapeutic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Covid-19 Therapeutic Market Forecast (2019-2026)
• 7.2 Covid-19 Therapeutic Key Players in Europe (2019-2020)
• 7.3 Europe Covid-19 Therapeutic Market Size by Type (2015-2020)
• 7.4 Europe Covid-19 Therapeutic Market Size by Application (2015-2020)

8 China

• 8.1 China Covid-19 Therapeutic Market Forecast (2019-2026)
• 8.2 Covid-19 Therapeutic Key Players in China (2019-2020)
• 8.3 China Covid-19 Therapeutic Market Size by Type (2015-2020)
• 8.4 China Covid-19 Therapeutic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Covid-19 Therapeutic Market Forecast (2019-2026)
• 9.2 Covid-19 Therapeutic Key Players in Japan (2019-2020)
• 9.3 Japan Covid-19 Therapeutic Market Size by Type (2015-2020)
• 9.4 Japan Covid-19 Therapeutic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Covid-19 Therapeutic Market Forecast (2019-2026)
• 10.2 Covid-19 Therapeutic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Covid-19 Therapeutic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Covid-19 Therapeutic Market Size by Application (2015-2020)

11 India

• 11.1 India Covid-19 Therapeutic Market Forecast (2019-2026)
• 11.2 Covid-19 Therapeutic Key Players in India (2019-2020)
• 11.3 India Covid-19 Therapeutic Market Size by Type (2015-2020)
• 11.4 India Covid-19 Therapeutic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Covid-19 Therapeutic Market Forecast (2019-2026)
• 12.2 Covid-19 Therapeutic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Covid-19 Therapeutic Market Size by Type (2015-2020)
• 12.4 Central & South America Covid-19 Therapeutic Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Cadila Healthcare
  • 13.1.1 Cadila Healthcare Company Details
  • 13.1.2 Cadila Healthcare Business Overview and Its Total Revenue
  • 13.1.3 Cadila Healthcare Covid-19 Therapeutic Introduction
  • 13.1.4 Cadila Healthcare Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.1.5 Cadila Healthcare Recent Development
• 13.2 Johnson & Johnson
  • 13.2.1 Johnson & Johnson Company Details
  • 13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 13.2.3 Johnson & Johnson Covid-19 Therapeutic Introduction
  • 13.2.4 Johnson & Johnson Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.2.5 Johnson & Johnson Recent Development
• 13.3 ImmunoPrecise
  • 13.3.1 ImmunoPrecise Company Details
  • 13.3.2 ImmunoPrecise Business Overview and Its Total Revenue
  • 13.3.3 ImmunoPrecise Covid-19 Therapeutic Introduction
  • 13.3.4 ImmunoPrecise Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.3.5 ImmunoPrecise Recent Development
• 13.4 Novartis
  • 13.4.1 Novartis Company Details
  • 13.4.2 Novartis Business Overview and Its Total Revenue
  • 13.4.3 Novartis Covid-19 Therapeutic Introduction
  • 13.4.4 Novartis Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.4.5 Novartis Recent Development
• 13.5 AstraZeneca
  • 13.5.1 AstraZeneca Company Details
  • 13.5.2 AstraZeneca Business Overview and Its Total Revenue
  • 13.5.3 AstraZeneca Covid-19 Therapeutic Introduction
  • 13.5.4 AstraZeneca Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.5.5 AstraZeneca Recent Development
• 13.6 Cipla
  • 13.6.1 Cipla Company Details
  • 13.6.2 Cipla Business Overview and Its Total Revenue
  • 13.6.3 Cipla Covid-19 Therapeutic Introduction
  • 13.6.4 Cipla Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.6.5 Cipla Recent Development
• 13.7 AbbVie
  • 13.7.1 AbbVie Company Details
  • 13.7.2 AbbVie Business Overview and Its Total Revenue
  • 13.7.3 AbbVie Covid-19 Therapeutic Introduction
  • 13.7.4 AbbVie Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.7.5 AbbVie Recent Development
• 13.8 Bayer
  • 13.8.1 Bayer Company Details
  • 13.8.2 Bayer Business Overview and Its Total Revenue
  • 13.8.3 Bayer Covid-19 Therapeutic Introduction
  • 13.8.4 Bayer Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.8.5 Bayer Recent Development
• 13.9 Regeneron Pharmaceuticals
  • 13.9.1 Regeneron Pharmaceuticals Company Details
  • 13.9.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
  • 13.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Introduction
  • 13.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.9.5 Regeneron Pharmaceuticals Recent Development
• 13.10 Ascletis Pharma
  • 13.10.1 Ascletis Pharma Company Details
  • 13.10.2 Ascletis Pharma Business Overview and Its Total Revenue
  • 13.10.3 Ascletis Pharma Covid-19 Therapeutic Introduction
  • 13.10.4 Ascletis Pharma Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 13.10.5 Ascletis Pharma Recent Development
• 13.11 GlaxoSmithKline
  • 10.11.1 GlaxoSmithKline Company Details
  • 10.11.2 GlaxoSmithKline Business Overview and Its Total Revenue
  • 10.11.3 GlaxoSmithKline Covid-19 Therapeutic Introduction
  • 10.11.4 GlaxoSmithKline Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.11.5 GlaxoSmithKline Recent Development
• 13.12 Gilead Sciences
  • 10.12.1 Gilead Sciences Company Details
  • 10.12.2 Gilead Sciences Business Overview and Its Total Revenue
  • 10.12.3 Gilead Sciences Covid-19 Therapeutic Introduction
  • 10.12.4 Gilead Sciences Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.12.5 Gilead Sciences Recent Development
• 13.13 Pharmstandard
  • 10.13.1 Pharmstandard Company Details
  • 10.13.2 Pharmstandard Business Overview and Its Total Revenue
  • 10.13.3 Pharmstandard Covid-19 Therapeutic Introduction
  • 10.13.4 Pharmstandard Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.13.5 Pharmstandard Recent Development
• 13.14 Fujifilm Holdings
  • 10.14.1 Fujifilm Holdings Company Details
  • 10.14.2 Fujifilm Holdings Business Overview and Its Total Revenue
  • 10.14.3 Fujifilm Holdings Covid-19 Therapeutic Introduction
  • 10.14.4 Fujifilm Holdings Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.14.5 Fujifilm Holdings Recent Development
• 13.15 Zhejiang Hisun Pharmaceutical Co. Ltd
  • 10.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
  • 10.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview and Its Total Revenue
  • 10.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Introduction
  • 10.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
• 13.16 Roche
  • 10.16.1 Roche Company Details
  • 10.16.2 Roche Business Overview and Its Total Revenue
  • 10.16.3 Roche Covid-19 Therapeutic Introduction
  • 10.16.4 Roche Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.16.5 Roche Recent Development
• 13.17 Sanofi
  • 10.17.1 Sanofi Company Details
  • 10.17.2 Sanofi Business Overview and Its Total Revenue
  • 10.17.3 Sanofi Covid-19 Therapeutic Introduction
  • 10.17.4 Sanofi Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.17.5 Sanofi Recent Development
• 13.18 Pfizer
  • 10.18.1 Pfizer Company Details
  • 10.18.2 Pfizer Business Overview and Its Total Revenue
  • 10.18.3 Pfizer Covid-19 Therapeutic Introduction
  • 10.18.4 Pfizer Revenue in Covid-19 Therapeutic Business (2019-2020))
  • 10.18.5 Pfizer Recent Development

14 Market Dynamics

• 14.1 Drivers
• 14.2 Challenges
• 14.3 Porter’s Five Forces Analysis
• 14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer